David M. Stein

Elizabeth Weiswasser

Ellen E. Oberwetter

David I. Berl

Thomas S. Fletcher

Andrew V. Trask

Shaun P. Mahaffy

Teagan J. Gregory

Matthew D. Umhofer

Kathryn Kayali

Christopher Pepe

Jacob Hartman

Arthur Argall, III

Priyata Patel

Adam Pan

Andrew Goldsmith

Grace W. Knofczynski

Mary C. Y. Carroll

Sven E. Henningson, III

Jennalee Beazley

Alyssa J. Picard

Rhochelle Krawetz

Christian Gladden-Sorensen

Margaret E. Dayton

Chorong Song

New patent escalates biosimilar war: Regeneron hits Amgen's launched Pavblu® drug with claims for a stable `VEGF antagonist formulation` vital to EYLEA®.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
Williams & Connolly LLP	L4 C
David I. Berl	L5 C
Thomas S. Fletcher	L4 B
Andrew V. Trask	L3 C
Ellen E. Oberwetter	L2 A
Shaun P. Mahaffy	L2 B
Kathryn Kayali	L2 C
Adam Pan	L2 C
Arthur Argall, III	L2 E
Teagan J. Gregory	L1 C
Jennalee Beazley	L1 C
Rhochelle Krawetz	L1 C
Christian Gladden-Sorensen	-- -- --
Chorong Song	-- -- --
Paul Weiss Rifkind Wharton Garrison LLP	L3 C
Elizabeth Weiswasser	L5 A
Christopher Pepe	L2 B
Priyata Patel	L1 B
Kellogg Huber Hansen Todd Evans Figel PLLC	L2 C
Jacob Hartman	L1 C
Andrew Goldsmith	L1 C
Grace W. Knofczynski	L1 C
Mary C. Y. Carroll	L1 C
Sven E. Henningson, III	L1 C
Alyssa J. Picard	L1 D
Umhofer Mitchell & King LLPLocal	-- -- --
Matthew D. Umhofer	-- -- --
Margaret E. Dayton	-- -- --

Name	Ratings
Olson Stein LLP	-- -- --
David M. Stein	-- -- --

2:25-cv-05499

Regeneron Pharma Inc v. Amgen Inc